LONDON, April 23 (Reuters) - British drug development firm Vectura Group Plc said on Monday a phase two clinical study on its inhaled erectile dysfunction (ED) product had been successful. "It is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results